10-hydroxycamptothecin has been researched along with Experimental Neoplasms in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Attiogbe, MKI; Cao, L; Cao, YX; Du, SS; Fan, S; Hei, YY; Lei, H; Li, GY; Liu, YJ; Yang, XY; Yao, JC; Zhang, GM; Zhang, H; Zhang, SQ; Zhang, XY | 1 |
| Gong, N; Guo, HB; Guo, W; Liang, XJ; Wang, PC; Wang, YF; Wen, Y; Zhang, W | 1 |
| Hao, X; Jie, J; Li, W; Tian, B; Yu, C; Zhang, X; Zhou, M | 1 |
| Chen, M; Li, X; Lu, J; Luo, X; Wei, J | 1 |
| Chen, X; Nan, X; Yu, C; Zhang, X; Zhou, M | 1 |
| Chen, LM; Ding, Y; Fu, LW; Liang, YJ; Pan, QC; Xiong, HY; Yang, XP | 1 |
| Chai, LP; Su, ZZ; Xian, ZX | 1 |
7 other study(ies) available for 10-hydroxycamptothecin and Experimental Neoplasms
| Article | Year |
|---|---|
F10, a new camptothecin derivative, was identified as a new orally-bioavailable, potent antitumor agent.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Apoptosis; Biological Availability; Camptothecin; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Molecular Structure; Neoplasms, Experimental; Structure-Activity Relationship; Tumor Cells, Cultured | 2020 |
Carrier-free, self-assembled pure drug nanorods composed of 10-hydroxycamptothecin and chlorin e6 for combinatorial chemo-photodynamic antitumor therapy in vivo.
Topics: A549 Cells; Animals; Camptothecin; Cell Line, Tumor; Chlorophyllides; Female; Humans; MCF-7 Cells; Mice; Mice, Inbred BALB C; Mice, Nude; Nanotubes; Neoplasms, Experimental; Photochemotherapy; Porphyrins; Radiation-Sensitizing Agents; Xenograft Model Antitumor Assays | 2017 |
Functional core/shell drug nanoparticles for highly effective synergistic cancer therapy.
Topics: Animals; Antineoplastic Agents; Camptothecin; Female; Gold; Laser Therapy; Materials Testing; Metal Nanoparticles; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; Tissue Distribution; Xenograft Model Antitumor Assays | 2014 |
Spatial distribution and antitumor activities after intratumoral injection of fragmented fibers with loaded hydroxycamptothecin.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Camptothecin; Delayed-Action Preparations; Diffusion; Female; Hep G2 Cells; Humans; Injections, Intralesional; Mice; Nanocapsules; Nanofibers; Neoplasms, Experimental; Particle Size; Survival Rate; Tissue Distribution; Treatment Outcome | 2015 |
Shape regulated anticancer activities and systematic toxicities of drug nanocrystals in vivo.
Topics: Animals; Camptothecin; Cell Line, Tumor; Cell Survival; Crystallization; Drug Compounding; Female; Mice; Mice, Inbred BALB C; Nanoparticles; Neoplasms, Experimental; Particle Size; Treatment Outcome | 2016 |
[Experimental studies on treatment of nasopharyngeal carcinoma with combination regimen of hydroxycamptothecin and etoposide].
Topics: Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cell Survival; Disease Models, Animal; Drug Resistance, Neoplasm; Etoposide; Mice; Mice, Inbred BALB C; Mice, Nude; Nasopharyngeal Neoplasms; Neoplasm Transplantation; Neoplasms, Experimental; Topoisomerase I Inhibitors; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2003 |
[Inhibition of hydroxycamptothecin on laryngeal squamous carcinoma cell line].
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Camptothecin; Carcinoma, Squamous Cell; Disease Models, Animal; Flow Cytometry; Laryngeal Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Neoplasms, Experimental; S Phase; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2003 |